Adult Height in Girls with Central Precocious Puberty with Onset after 6 Years: Effects of Gonadotropin-Releasing Hormone Analog Therapy
Hormone Research in Paediatrics · 2024
DOI: 10.1159/000542038 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Hormone Research in Paediatrics, 2024. Verfasst von Reiko Saito und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. Hauptthemen laut MEDLINE: Puberty, Precocious, Gonadotropin-Releasing Hormone, Body Height. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Introduction
Precocious puberty (PP), which is sometimes divided into gonadotropin-dependent or gonadotropin-independent PP, is a pathological condition characterized by premature secretion of gonadal steroids resulting in the early development of secondary sexual characteristics. Girls younger than 6 years with idiopathic gonadotropin-dependent PP (referred to as central PP or CPP) who receive gonadotropin-releasing hormone analog (GnRHa) therapy experience an increase in their adult height (AH) in contrast to girls who are aged 6 years or more, who show no consistent pattern of increase even with GnRHa therapy.
Methods
In total, 133 girls aged 6 years or more who visited any one of the seven study centers between April 2000 and March 2020 and who met the diagnostic criteria for PP in Japan were retrospectively examined. The participants were divided into a treatment (n = 56) and no-treatment group (n = 77). The AH and target height (TH) were compared between the groups, and the factors influencing the AH were examined.
Results
The patients receiving GnRHa therapy achieved significantly greater increase in their AH, AH − TH, and predicted AH at the age of 6, 7, and 8 years (6 ≤ years < 9) than those without the treatment. The TH and height at the start and end of treatment influenced the AH of the former group.
Conclusion
GnRHa therapy was effective in improving the AH in girls with CPP onset at the age of 6, 7, or 8 years. The TH was a strong determinant of the AH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
- Department of Endocrinology and Metabolism, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
- Department of Pediatrics, Shinyurigaoka General Hospital, Kawasaki, Japan.
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
- Division of Pediatrics, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
- Department of Pediatrics, Hokkaido University School of Medicine, Sapporo, Japan.
Zitieren
APA
Saito, R., Ozaki, K., Baba, Y., Ikegawa, K., Nagasaki, K., Nakamura, A., Hamajima, T., Higuchi, S., & Hasegawa, Y. (2024). Adult Height in Girls with Central Precocious Puberty with Onset after 6 Years: Effects of Gonadotropin-Releasing Hormone Analog Therapy. Hormone Research in Paediatrics. https://doi.org/10.1159/000542038
Vancouver
Saito R, Ozaki K, Baba Y, Ikegawa K, Nagasaki K, Nakamura A, et al. Adult Height in Girls with Central Precocious Puberty with Onset after 6 Years: Effects of Gonadotropin-Releasing Hormone Analog Therapy. Hormone Research in Paediatrics. 2024. doi:10.1159/000542038
BibTeX
@article{Saito2024,
author = {Saito, Reiko and Ozaki, Kayo and Baba, Yoshiro and Ikegawa, Kento and Nagasaki, Keisuke and Nakamura, Akie and Hamajima, Takashi and Higuchi, Shinji and Hasegawa, Yukihiro},
title = {Adult Height in Girls with Central Precocious Puberty with Onset after 6 Years: Effects of Gonadotropin-Releasing Hormone Analog Therapy},
journal = {Hormone Research in Paediatrics},
year = {2024},
doi = {10.1159/000542038}
}
EUVIMED